Serum Peptidyl-prolyl Cis-trans Isomerase NIMA-interacted 1 (Pin1) as a Non-invasive Marker for Liver Fibrosis due to Chronic Hepatitis C Virus.
Open Access
- 3 October 2021
- journal article
- research article
- Published by Briefland in Hepatitis Monthly
- Vol. 21 (7)
- https://doi.org/10.5812/hepatmon.116687
Abstract
Background: Hepatitis C virus (HCV) may remain asymptomatic or cause liver fibrosis and cirrhosis. Objectives: We aimed to assess the relationship between serum peptidyl-prolyl cis-trans isomerase NIMA-interacted 1 (Pin1) levels and liver fibrosis due to HCV. Methods: Serum samples of successive patients with HCV genotype 1b and healthy volunteers were collected, and Pin1 levels were measured using ELISA kits. Liver fibrosis stages were calculated by the Ishak Scoring System and subdivided into two groups; stage < 3 (mild fibrosis) and ≥ 3 (advanced fibrosis). Correlation and area under receiver operating characteristics (AUROC) analysis were used to investigate the relationship between Pin1 and clinical and histopathological properties of HCV infection. Results: Ninety-four patients with HCV and 47 age- and sex-matched volunteers were included. The median age of the participants was 52, and 55% of whom were females. The mean (SD) of Pin1 serum level was significantly higher in the HCV group compared with healthy volunteers (33.94 (21.15) vs. 26.82 (8.85) pg/mL, respectively, P = 0.007). Seventy-seven (82%) and 17 (18%) of the participants showed mild and advanced fibrosis, respectively. Pin1 serum levels were significantly lower in the mild compared with advanced fibrosis group (29 (17.88) vs. 43.59 (7.98) pg/mL, respectively, P < 0.001). We found a significantly positive correlation between Pin1 serum level and liver fibrosis stage (r = 0.71, P < 0.001). The cut off of 33.04 pg/mL of Pin1 serum level showed the best sensitivity (100%) and specificity (68.4%) (AUROC = 0.81 [95% confidence interval: 0.72 - 0.90], P < 0.001) for distinguishing advanced from mild liver fibrosis. Conclusions: Serum Pin1 level may be a relevant marker for predicting liver fibrosis in HCV infected patients. Keywords Pin1 Non-invasive Serum Marker Hepatic Fibrosis Chronic Hepatitis C Virus infectionKeywords
This publication has 23 references indexed in Scilit:
- Non-invasive diagnosis of liver fibrosis in chronic hepatitis CWorld Journal of Gastroenterology, 2014
- Role of Pin1 Protein in the Pathogenesis of Nonalcoholic Steatohepatitis in a Rodent ModelJournal of Biological Chemistry, 2012
- Peptidyl-Prolyl Isomerase Pin1 Is a Cellular Factor Required for Hepatitis C Virus PropagationJournal of Virology, 2011
- Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon–mediated immunityNature Immunology, 2011
- Pin1 Associates with and Induces Translocation of CRTC2 to the Cytosol, Thereby Suppressing cAMP-responsive Element Transcriptional Activity*Online Journal of Public Health Informatics, 2010
- Noninvasive assessment of liver fibrosisJournal of Hepatology, 2010
- Proline cis/trans-Isomerase Pin1 Regulates Peroxisome Proliferator-activated Receptor γ Activity through the Direct Binding to the Activation Function-1 Domain*Online Journal of Public Health Informatics, 2010
- Pin1 regulates TGF-β1 production by activated human and murine eosinophils and contributes to allergic lung fibrosisJCI Insight, 2008
- SAP Regulates TH2 Differentiation and PKC-θ-Mediated Activation of NF-κB1Immunity, 2004
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995